Mometasone Dry Powder Inhaler (Formulation B)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Mometasone Dry Powder Inhaler (Formulation B), covering 2024-08-15 to 2024-08-15. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Determine the Efficacy and Safety of Two Mometasone Dry Powder Inhalers in the Treatment of Asthma (Study P02524) [Phase 3]